CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost From organic and inorganic phosphates to valvular and vascular calcifications Patient and Hospital Characteristics of Mitral Valve Surgery in the United States Mode of Death in Heart Failure With Preserved Ejection Fraction A Novel Familial Cardiac Arrhythmia Syndrome with Widespread ST-Segment Depression Digital learning and the future cardiologist
|<<... 61 62 63 64 65 66 67 ...>>|

Original Research2018 Aug 27.

JOURNAL：N Engl J Med. Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia JF, Messika-Zeitoun D, MITRA-FR Investigators et al. Keywords: chronic heart failure; reduced left ventricular ejection fraction; severe secondary mitral-valve regurgitation; percutaneous mitral-valve repair;clinical outcome

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top